Distribution of hyperglycaemia and related cardiovascular disease risk factors in low-income countries: A cross-sectional population-based survey in rural Uganda

International Journal of Epidemiology

Volumn 40, Issue 1, 2011, Pages 160-171

  Maher, Dermot ^a,b   Waswa, Laban ^a   Baisley, Kathy ^b   Karabarinde, Alex ^a   Unwin, Nigel ^c   Grosskurth, Heiner ^a,b  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Africa; Cardiovascular disease; Prevalence

Indexed keywords

GLUCOSE;

BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DEVELOPING WORLD; DIABETES; DISEASE PREVALENCE; EPIDEMIOLOGY; OBESITY; QUESTIONNAIRE SURVEY; RISK FACTOR; RURAL POPULATION; SMOKING; SOCIOECONOMIC STATUS; WOMENS HEALTH;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RURAL AREA; SEX RATIO; UGANDA; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; POPULATION SURVEILLANCE; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; RURAL POPULATION; UGANDA;

UGANDA;

EID: 79952045540     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyq156     Document Type: Article

References (51)

1. International Diabetes Federation. Diabetes Atlas. 4th edn. Brussels: International Diabetes Federation, 2010.
2. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
3. World Health Organization. Obesity and overweight. Fact sheet no. 311. http://www.who.int/mediacentre/factsheets/fs311/en/index.html (accessed 15 January 2010).
4. Magnusson R. Developing a global framework to address non-communicable diseases. Diabetes Voice 2008;53:9-12.
5. Beaglehole R, Epping-Jordan J, Patel V et al. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary care. Lancet 2008;372:940-49.
6. Jeon CY, Murray MB. Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies. PLoS Med 2008;5:e152. doi:10.1371/journal.pmed.0050152.
7. Daar AS, Singer PA, Persad DL et al. Grand challenges in chronic non-communicable diseases. Nature 2007;450: 494-96.
8. United Kingdom Department for International Development (DFID). Research Strategy 2008-2013. London: DFID, 2008.
9. World Health Organization. 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. Geneva: World Health Organization, 2008.
10. Nabel EG, Stevens S, Smith R. Combating chronic disease in developing countries. Lancet 2009;373:2004-6.
11. Tollman SM, Kahn K, Sartorius B, Collinson MA, Clark SJ, Garenne ML. Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study. Lancet 2008;372: 893-901.
12. World Health Organization. The World Health Report 2004: Changing History. Geneva: World Health Organization, 2004.
13. Editorial. Hypertension: uncontrolled and conquering the world. Lancet 2007;370:539.
14. Anonymous. Diabetes - a global threat. (Editorial). Lancet 2009;373:17.
15. International Diabetes Federation. Diabetes atlas. http://www.diabetesatlas.org/content/africa (10 January 2010, date last accessed).
16. Beaglehole R, Ebrahim S, Reddy S, Voute J, Leeder S. Prevention of chronic diseases: a call to action. Lancet 2007;370:2152-57.
17. Nunn AJ, Mulder DW, Kamali A, Ruberantwari A, Kengeya-Kayondo JF, Whitworth J. Mortality associated with HIV-1 infection over five years in a rural Ugandan population: cohort study. BMJ 1997;315:767-71.
18. Kengeya-Kayondo JF, Kamali A, Nunn AJ, Ruberantwari A, Wagner H-U, Mulder DW. Incidence of HIV-1 infection in adults and socio-demographic characteristics of seroconverters in a rural population in Uganda: 1990-1994. Int J Epidemiol 1996;25:1077-82.
19. UNICEF. The State of the World's Children. New York: UNICEF, 2008.
20. Nakibinge S, Maher D, Katende J, Kamali A, Grosskurth H, Seeley J. Community engagement in health research: two decades of experience from a research project on HIV in rural Uganda. Tropical Medicine and International Health 2009;14:190-95.
21. Tolonen H, Kuulasmaa K, Laatikainen T, Wolf H. and the European Health Risk Monitoring Project. Recommendations for Indicators, International Collaboration, Protocol and Manual of Operations for Chronic Disease Risk Factor Surveys. Helsinki: European Health Risk Monitoring, 2002.
22. Cuckson AC, Reinders A, Shabeeh H, Shennan AH. Validation of the Microlife BP 3BTO-A oscillometric blood pressure monitoring device according to a modified British Hypertension Society protocol. Devices and Technology 2002;7:319-24.
23. World Health Organization. WHO Expert Committee. Physical Status: The Use and Interpretation of Anthropometry. WHO Technical Report Series No. 854. Geneva: WHO, 1995.
24. U.S. Department of Agriculture, U.S. Department of Health and Human Services. Dietary Guidelines for Americans. 3rd edn. Washington, DC: Government Printing Office, 1990.
25. International Diabetes Federation (IDF). Worldwide Definition of the Metabolic Syndrome. Brussels: International Diabetes Federation, 2006.
26. World Health Organization (WHO). International Society of Hypertension (ISH) Writing Group. WHO/ISH statement on management of hypertension. J Hyperten 2003; 21:1983-92.
27. World Health Organization (WHO) and International Diabetes Foundation (IDF). Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva: WHO, 2006.
28. van der Sande MAB, Bailey R, Faal H et al. Nationwide prevalence study of hypertension and related non-communicable diseases in The Gambia. Tropical Medicine and International Health 1997;2:1039-48.
29. Aspray TJ, Mugusi F, Rashid S et al. Essential Non-Communicable Disease Health Intervention Project: Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg 2000;94:637-44.
30. Christensen DL, Friis H, Mwaniki DL et al. Prevalence of glucose intolerance and associated risk factors in rural and urban populations of different ethnic groups in Kenya. Diabetes Res Clin Pract 2009;84:303-10.
31. Motala AA, Esterhuizen T, Gouws E et al. Diabetes and other disorders of glycemia in a rural South African community: prevalence and associated risk factors. Diabetes Care 2008;31:1783-88.
32. Lasky D, Becerra E, Boto W, Otim M, Ntambi J. Obesity and gender differences in the risk of type 2 diabetes mel-litus in Uganda. Nutrition 2002;18:417-21.
33. Amoah AG, Owusu SK, Adjei S. Diabetes in Ghana: a community based prevalence study in Greater Accra. Diabetes Res Clin Pract 2002;56:197-205.
34. Balde N-M, Diallo I, Balde M-D et al. Diabetes and inpaired fasting glucose in rural and urban populations in Futa Jallon (Guinea): prevalence and associated risk factors. Diabetes Metab 2007;33:114-20.
35. Zhu S, Heymsfield S, Toyoshima H, Wang Z, Pietrobelli A, Heshka S. Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors. Am J Clin Nutr 2005;81:409-15.
36. Wamala JF, Karyabakabo Z, Ndungutse D, Guwatudde D. Prevalence factors associated with hypertension in Rukungiri District, Uganda - a community-based study. Afr Health Sci 2009;9:153-60.
37. Addo J, Smeeth L, Leon DA. Hypertension in sub-Saharan Africa: a systematic review. Hypertension 2007; 50:1012-18.
38. Bovet P, Gervasoni J-P, Ross AG et al. Assessing the prevalence of hypertension in populations: are we doing it right? J Hyperten 2003;21:509-17.
39. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23.
40. Uganda Bureau of Statistics. Uganda Demographic and Health Survey 2006. Calverton, MD: UBOS and Macro International Inc, 2007.
41. Ziraba AK, Fotso JC, Ochako R. Overweight and obesity in urban Africa: a problem of the rich or the poor? BMC Public Health 2009;9:465.
42. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk. Evidence in support of current National Institutes of Health guidelines. Arch Intern Med 2002;162:2074-79.
43. World Health Organization (WHO). Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva: WHO, 1999.
44. Ziemer DC, Kölm P, Foster JK et al. Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2. J Gen Intern Med 2008;23:528-35.
45. Ziemer DC, Kölm P, Weintraub WS et al. Age, BMI, and race are less important than random plasma glucose in identifying risk of glucose intolerance: the Screening for Impaired Glucose Tolerance Study (SIGT 5). Diabetes Care 2008;31:884-86.
46. El Bassuoni EA, Ziemer DC, Kölm P et al. The "metabolic syndrome" is less useful than random plasma glucose to screen for glucose intolerance. Prim Care Diabetes 2008;2: 147-53.
47. Chan AYW, Swaminathan A, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem 1989;35:315-17.
48. Steyn K, Sliwa K, Hawken S et al. INTERHEART Investigators in Africa. Risk factors associated with myo-cardial infarction in Africa: the INTERHEART Africa study. Circulation 2005;112:3536-40.
49. Abubakari AR, Lauder W, Jones MC, Kirk A, Agyemang C, Bhopal RS. Prevalence and time trends in diabetes and physical inactivity among adult West African populations: the epidemic has arrived. Public Health 2009;123:602-14.
50. Nugent RA, Yach D, Feigl AB. Non-communicable diseases and the Paris Declaration. Lancet 2009;374: 784-85.
51. Anonymous. The global alliance for chronic diseases. Lancet 2009;373:2084.